期刊文献+

超高效液相色谱法测定人体血浆中水杨酸含量的方法学研究

Determination of Salicylic Acid in the Human Plasma by Ultra Performance Liquid Chromatography
下载PDF
导出
摘要 目的:建立人体血浆中水杨酸含量的超高效液相色谱(ultra performance liquid chromatography,UPLC)测定方法。方法:采用Waters Spursil C18(100 mm×2.10 mm,3μm)色谱柱;乙腈∶水(含0.2%磷酸)=20.7∶79.3为流动相,用前经0.22μm的滤膜过滤,超声脱气;流速为0.3 ml/min;检测波长为304 nm;柱温为35℃,进样量5μl。结果:此方法最低检测浓度为0.018 mg/L,线性范围为0.018~28.200 mg/L,方法平均回收率在95.52%~104.63%,日内及日间精密度的相对标准差均<10%。结论:该方法简便、快速、重现性好,可用于临床血药浓度监测和复方制剂的药代动力学和生物利用度研究。 Objective:To determine salicylic acid in the human plasma by ultra performance liquid chromatography(UPLC).Methods:Salicylic acid was successfully separated using a Waters Spursil C18 column.The mobile phase consisted of acetonitrile-0.2%phosphoric acid(20.7∶79.3) and was degassed ultrasonically before use.Each component of the mobile phase was filtered through a 0.22 μm membrane.The column temperature was 35℃,the flow rate was 0.3 ml/min and detection wavelength was 304 nm.Injection volume was 5 μl.Results:The detection limit was 0.018 mg/L.The linear range was 0.018~28.200 mg/L.The average recovery was 95.52%~104.63%.RSD of intra-day and inter-day was less than 10%.Conclusions:The method is convenient,fast,reproducible.and can be used for determination simultaneously of concentration of salicylic acid in human plasma.It is suitable for therapeutic monitoring and the pharmacokinetics study.
出处 《沈阳医学院学报》 2012年第2期93-95,共3页 Journal of Shenyang Medical College
关键词 超高效液相色谱法 水杨酸 血浆 ultra performance liquid chromatography; salicylic acid; plasma
  • 相关文献

参考文献5

二级参考文献20

  • 1杨燕云,李文平,刘茜,尚宏伟,杨伦,郭雪海.HPLC测定阿司达莫缓释片的含量[J].华西药学杂志,2007,22(3):336-338. 被引量:6
  • 2[1]William T,Bwaver MD.Aspirin and ccetaminophen as constituents of analgesic combinations. ArchIntern Med,1981;141
  • 3[2]William T,Bwaver MD.Combination Analgesics. The American Journal of Medicine,1984; 10∶38
  • 4[3]FDA extends excedrin migraine indication to full migraine syndrome.Doctor's Guide,October 13,1999
  • 5[4]Katori M. Pharmacology of prostaglandins;theirprofile and characterization in the body.Nippon Yakurigaku Zasshi, 1989;94(3)∶159
  • 6[5]Graham JRW Wolff HG.Mechanism of migraine headache and action of ergotamine tartrate.Arch Neurol Psychiatry, 1938; 39∶737
  • 7陈新谦 金有豫 汤光.新编药物学[M].北京:人民卫生出版社,2003.457.
  • 8The SALT Collaborative Group.Swedish Aspirin Low-Dose Trial (SALT) of 75mg aspirin as secondary prophylaxis after cerebrovascular ischemia events[J].Lancet,1991,338 (8779):1345-1349.
  • 9ALBERS GW,AMARENCO P,EASTON JD,et al.Antithrombotic and thrombolytic therapy for ischemic stroke[J].Chest,2001,119(1 Suppl):S300-S320.
  • 10MCMAHON GP,KELLY MT.Determination of aspirin and salicylic acid in human plasma by column-switching liquid chromatography using on-line solid-phase extraction[J].Anal Chem,1998,70(2):409 -414.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部